Therapeutic Bioactivity Exerted by the Apis mellifera Bee Venom and Its Major Protein Melittin: A Scoping Review
Molecules · 2025
DOI: 10.3390/molecules30194003 ↗Kurz gefasst
Scoping Review in der Zeitschrift Molecules, 2025. Verfasst von Perihan Mutlu Erdoğan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, 61080 Trabzon, Türkiye. Hauptthemen laut MEDLINE: Bee Venoms, Melitten. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 431 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Honey bee (Apis mellifera) products have been extensively utilized in traditional medicine. Bee venom (BV) is one of the major bee products with a high concentration of the small peptide melittin (MEL) and exerts bioactivity ranging from anti-microbial to anti-inflammatory and anti-cancer. This scoping review aims to sum up research articles on the bioactivity exerted by BV and MEL published in PubMed and Scopus from 2010 onwards. PRISMA guidelines were implemented to analyze the relevant literature; we ended up with 425 research articles. Bioactivity of BV and MEL was grouped as (i) anti-inflammatory (85), (ii) immunomodulatory (37), (iii) anti-microbial (179), (iv) anti-cancer (170), and (v) anti-oxidant (32). Although there is a significant body of research on the anti-cancer and anti-microbial activity of BV and MEL, their anti-oxidant, anti-inflammatory and immunomodulatory properties have received comparatively less attention. Many studies on the immunomodulatory effects of BV or MEL have focused on cancer. However, the effects on Parkinson’s and Alzheimer’s disease have not been extensively studied regarding the anti-inflammatory effects. Given the critical role of the immune system and inflammatory response in cancer, neurodegenerative diseases, senescence and against infections, it is paramount to further explore the immunomodulatory and anti-inflammatory potential of BV and MEL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, 61080 Trabzon, Türkiye.
- Graduate School of Natural and Applied Science, Karadeniz Technical University, 61080 Trabzon, Türkiye.
- Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Türkiye.
- Trabzon Teknocity, Okta R&D Eng Services Industry Trade Limited Company, 61080 Trabzon, Türkiye.
- Gumushane University, Rectorate, 29100 Gümüşhane, Türkiye.
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, 61080 Trabzon, Türkiye.
ORCID-Profile: Perihan Mutlu Erdoğan, Selcen Çelik-Uzuner, Dimitris Mossialos
Zitieren
APA
Erdoğan, P. M., Bilgili-Tetikoğlu, F., Çelik-Uzuner, S., Yıldız, O., Kolayli, S., & Mossialos, D. (2025). Therapeutic Bioactivity Exerted by the Apis mellifera Bee Venom and Its Major Protein Melittin: A Scoping Review. Molecules. https://doi.org/10.3390/molecules30194003
Vancouver
Erdoğan PM, Bilgili-Tetikoğlu F, Çelik-Uzuner S, Yıldız O, Kolayli S, Mossialos D. Therapeutic Bioactivity Exerted by the Apis mellifera Bee Venom and Its Major Protein Melittin: A Scoping Review. Molecules. 2025. doi:10.3390/molecules30194003
BibTeX
@article{Erdoan2025,
author = {Erdoğan, Perihan Mutlu and Bilgili-Tetikoğlu, Funda and Çelik-Uzuner, Selcen and Yıldız, Oktay and Kolayli, Sevgi and Mossialos, Dimitris},
title = {Therapeutic Bioactivity Exerted by the Apis mellifera Bee Venom and Its Major Protein Melittin: A Scoping Review},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30194003}
}
EUVIMED